Drugs / AZD4316
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01247103 Comparator | Dec 2010 → Jun 2011 | — | AstraZeneca | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD4316 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01247103 ↗ |
| Modality | Small molecule | — CHEMBL5095216 ↗ |
| Route | Oral | “Single oral doses of AZD4316 suspension in the fasted state.” NCT01247103 ↗ |